Fundz

Hemispherian Secures Eur 10M In Financing From The European Innovation Council (Eic) Accelerator Program

PRIVATEOct 19, 2022

Amount Raised

€10 Million

Round Type

Funding Round

OsloBiotechnologyHealth CareScience And EngineeringPrivacy And Security

Description

Hemispherian AS ("Hemispherian'' or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce a successful European Innovation Council (EIC) Accelerator grant application. This grant will provide EUR 2.5M in grant funding and the jury recommends an additional EUR 7.5M in equity financing from the EIC fund. Financing from the EIC accelerator will be used to advance GLIX1, one of Hemispherian's lead assets, through a phase I and phase II clinical trial.

Quick answer

Hemispherian AS raised €10 Million in a Funding Round round, dated October 19, 2022. Hemispherian AS is based in Oslo, Norway.

How much did Hemispherian AS raise?
Hemispherian AS raised €10 Million in a Funding Round round on October 19, 2022.
What does Hemispherian AS do?
Hemispherian is an innovative pharmaceutical company focused on developing a novel class of small molecule drugs (GLIX).
Where is Hemispherian AS based and how big is it?
Hemispherian AS is based in Oslo, Norway.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Privacy And Security around the same time

Companies in the same sectors as Hemispherian AS that raised within 45 days of this round, from Fundz verified event records.

  • Trait Biosciences Inc. raised $230K (Series A) on November 16, 2022.
  • Appili Therapeutics Inc. raised $14M (Funding Round) on November 14, 2022.
  • Variantyx raised $20M on October 18, 2022.
  • Viome raised $67M (Series C) on October 18, 2022.
  • Wheeler Bio raised an undisclosed amount (Series A) on October 4, 2022.
  • Viome raised $67M on September 27, 2022.

Who to call at Hemispherian AS, and when

A new round usually means Hemispherian AS is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hemispherian AS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hemispherian AS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hemispherian AS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hemispherian AS

Location

Oslo, Norway

About

Hemispherian is an innovative pharmaceutical company focused on developing a novel class of small molecule drugs (GLIX). GLIX compounds target the TET2 enzyme and activate the DNA damage response resulting in cancer cell death. The company's lead compound, GLIX1, is in late-stage preclinical development for the treatment of glioblastoma multiforme, a deadly cancer of the central nervous system and the leading cause of death by disease in children. Hemispherian is further focused on developing a companion diagnostic tool to support patient selection for optimal therapeutic response to GLIX1. Hemispherian is based in Oslo, Norway. For more information, visit www.hemispherian.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hemispherian AS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hemispherian AS's next move

See what Strategic adds

Hemispherian AS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.